The PREPAIRD Study: Personalized Surveillance for Early Detection of Pancreatic Cancer in High Risk Individuals

You may be eligible if

• 1. Men or women with a germline mutation in CDKN2A, TP53, PRSS1 or STK11
• 2. Men or women who are first degree relatives to a patient with pancreatic cancer (PC) in a family with Familial Pancreatic Cancer (FPC).